Back

Cardio-kidney-metabolic overlap in patients with severe heart failure: data from the HELP-HF registry

10 May 2026 (09:30 - 10:15)
Organised by: Logo
Congress Presentation Part of: Navigating the cardio-renal syndrome (1) Comorbidities Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Alessandro Villaschi

Humanitas University, Milan (Italy)

5 More presentations in this session

Presentation thumbnail
Undiagnosed chronic kidney disease, outcomes, and finerenone in heart failure with preserved ejection fraction
Doctor J. Ostrominski (Boston, US)
Abstract Slides
Presentation thumbnail
Care discrepancy in the management of the cardiorenal-metabolic syndrome: real-world analysis of SGLT2 inhibitor use in heart failure, chronic kidney disease, and type 2 diabetes
Miss E. Ziegler (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Clinical impact of renal function deterioration while awaiting heart transplantation in patients bridged with left ventricular assist devices: a multicenter analysis of the UNOS database
Associate Professor R. Asleh (Jerusalem, IL)
Abstract Slides
Presentation thumbnail
Worsening renal function in heart failure is less harmful if associated with optimization of heart failure medication: insights from a large Registry.
Doctor D. Tomasoni (Brescia, IT)
Abstract Slides
Presentation thumbnail
Prognostic impact of cardio-renal-metabolic syndrome in HFrEF from an emerging economy
Doctor A. Perez Perez (Mexico City, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Navigating the cardio-renal syndrome (1)

The Event

Event poster

Heart Failure 2026

10 May 2026 09:30 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of cardiovascular-kidney-metabolic overlap among patients with acute heart failure: insights from a real-world multinational cohort
thumbnail
Congress Presentation
Opportunities to incorporate heart failure prevention strategies
thumbnail
Congress Presentation
Cardio-Kidney-metabolic overlap in HFpEF: cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources